- Home
- CNSP vs CHNR Comparison
CNSP vs CHNR Comparison
Compare CNSP & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNSP | CHNR |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.7M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CNSP | CHNR |
|---|---|---|
| Price | $7.05 | $3.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 19.1K |
| Earning Date | 11-17-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.93 | $3.16 |
| 52 Week High | $114.00 | $8.20 |
Technical Indicators
Market Signals| Indicator | CNSP | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 48.63 | 45.79 |
| Support Level | $6.11 | $3.75 |
| Resistance Level | $8.10 | $4.31 |
| Average True Range (ATR) | 0.52 | 0.27 |
| MACD | 0.13 | 0.10 |
| Stochastic Oscillator | 47.24 | 43.35 |
Price Performance
Historical ComparisonAbout CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.